Navigation Links
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
Date:3/12/2008

d

net loss per

share(1) $(0.50) $(0.53) $(1.81) $(10.07)

Shares used to

compute basic and

diluted net loss

per share(1) 28,699,215 16,816,445 28,572,883 5,181,920

(1) As a result of the issuance of 6,900,000 shares of common stock in

the Company's initial public offering in the fourth quarter of 2006

and the conversion of the Company's preferred stock into 19,907,605

shares of common stock upon completion of the Company's initial

public offering, there is a lack of comparability in the per share

amounts between the 2006 and 2007 periods presented.

CADENCE PHARMACEUTICALS, INC.

(a development stage company)

CONDENSED BALANCE SHEETS

December 31, December 31,

2007 2006

(unaudited)

Assets

Current assets:

Cash and cash equivalents $55,392,921 $86,825,526

Restricted cash 1,981,848 347,849

Prepaid expenses and other current assets 959,321 820,311

Total current assets 58,334,090 87,993,686

Property and equipment, net 5,139,538 3,558,618

Restricted cash 885,434 1,233,281

Other assets 252,963 306,598

Total assets $64,612,025 $93,092,183

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable $1,974,991 $2,073,726

Accrued liabilities 13,901,7
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
2. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
3. ISTA Pharmaceuticals to Present at the Cowen & Company 28th Annual Health Care Conference
4. SGX Pharmaceuticals Announces Fourth Quarter and Full Year Financial Results
5. Onyx Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
6. Idenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference
7. Drinking Water Association Discusses Pharmaceuticals in Water
8. Genesis Pharmaceuticals Changes Auditors
9. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
10. Statement from American Water Works Association on Associated Press Story on Pharmaceuticals in Drinking Water
11. Vion Pharmaceuticals Regains NASDAQ Listing Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... ... today, especially in wound center management. Earlier this year Wound Care Advantage ... education and training for WCA wound centers. Customized learning paths allow for ...
(Date:7/27/2015)... ... July 27, 2015 , ... In a piece published July ... of plastic surgery and explained why people should not shy away from their own ... excesses of the few and celebrate it for the modern wonder that it is.” ...
(Date:7/27/2015)... ... ... North Central Surgical Center Hospital will be holding twice-monthly joint wellness classes ... patients, along with their friends and family members, to attend. The classes take place ... 8 [Tue due to Labor Day], Oct 5, Nov 2, Dec 7) beginning at ...
(Date:7/27/2015)... ... ... A Harris County jury awarded a group of Texas and Canadian investors approximately ... on findings of fraud and violations of the Texas Securities Act. The verdict was ... 2010-09675; Jo Ann Schermerhorn, et al v. CenturyLink, Inc. and Robert Kubbernus, et al., ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... To Reduce Hospital Readmissions." , The Centers for Medicare and Medicaid Services (CMS) ... as part of their penalty calculation. Known as the QualityNet Hospital-Specific Report (HSR), ...
Breaking Medicine News(10 mins):Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 2Health News:Wound Care Advantage Launches Luvo University An Online Hub For Wound Care Education and Training 3Health News:Recent Op-Ed Defending Plastic Surgery Highlights the Personal Side of Cosmetic Procedures, says Beverly Hills Physicians 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 2Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 3Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 4Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 5Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 6Health News:BESLER Consulting Publishes E-book Focused on Reducing Hospital Readmissions 2
... On the eve of President Obama,s healthcare summit ... said today that expanding and updating Medicare to ... approach to achieving the goals and principles outlined ... Congress and budget proposal.While welcoming President Obama,s call ...
... University Baptist Medical Center, and colleagues, have identified a ... people with cystic fibrosis, a lethal genetic condition. The ... treatment, researchers say. , The study appeared online last ... . It is the first published study to search ...
... IDIX ) announced today that management will present ... Conference on Tuesday, March 10th at 1:30 p.m. ET at ... Company 29th Annual Healthcare Conference on Tuesday , March ... Marriott Copley Place.The live and archived webcasts of the presentations ...
... WXYZ is proud to announce that ... Nielsen , will now be seen exclusively on Channel ... 15 years Peter Nielsen has hosted the nationally syndicated ... author of numerous books and videos on health and fitness and is ...
... Genaera Corporation (Nasdaq: GENR ) today announced its financial ... net loss for the year ended December 31, 2008 was $16.0 ... a net loss of $15.7 million, or $(0.90) per share basic ... loss for the quarter ended December 31, 2008 was $3.6 million, ...
... percent increased chance of death, rehospitalization , , TUESDAY, March ... blood thinner Plavix, plus a proton pump inhibitor such ... of death or another heart attack, a new study ... help reduce the risk of another heart attack after ...
Cached Medicine News:Health News:Nation's RNs on the Healthcare Summit: Insurance-Based Reform Will Fail, and Undermine Public Trust, Only Medicare for All Can Achieve Administration's Goals 2Health News:Nation's RNs on the Healthcare Summit: Insurance-Based Reform Will Fail, and Undermine Public Trust, Only Medicare for All Can Achieve Administration's Goals 3Health News:Scientists find gene that modifies severity of cystic fibrosis lung disease 2Health News:Scientists find gene that modifies severity of cystic fibrosis lung disease 3Health News:Peter Nielsen Has a New Home on WXYZ-TV! 2Health News:Genaera Corporation Announces 2008 Financial Results 2Health News:Genaera Corporation Announces 2008 Financial Results 3Health News:Genaera Corporation Announces 2008 Financial Results 4Health News:Genaera Corporation Announces 2008 Financial Results 5Health News:Blood Thinner, Heartburn Drugs May Be Risky After Heart Attack 2Health News:Blood Thinner, Heartburn Drugs May Be Risky After Heart Attack 3
(Date:7/27/2015)... 27, 2015  Array BioPharma Inc. (Nasdaq: ... the fourth quarter and full year of ... to discuss those results on Monday, August ... will lead the call.  Date:Monday, ... 507-2598Pass Code: 68380312 Webcast, including Replay and ...
(Date:7/27/2015)... July 27, 2015 As per the ... - Global Industry Analysis, Size, Share, Growth, Trends and Forecast ... 7.96 billion in 2014, growing at a CAGR of 13.2% ... in 2021. The global bionics market is growing ... which is leading to paralysis or amputation of body parts. ...
(Date:7/27/2015)... , July 20, 2015 Research and ... the "Medical Device Regulation in Asia/Pacific Markets Seminar" ... that the European Medical Device market is well established, ... . China , together with other ... in the process of implementing, their own medical device ...
Breaking Medicine Technology:Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 2Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 3Global Bionics Market is Expected to Reach USD 20.49 Billion in 2021, Growing at CAGR of 13.2% From 2015 to 2021: Transparency Market Research 4Medical Device Regulation in Asia/Pacific Markets Seminar: London, UK - 21st, 22nd of September 2015 2
... Advances and Expands Internal Pipeline as DARA Program Enters ... Development and New SARM Program is Added, PRINCETON, ... for the quarter and nine months ended,September 30, 2007, ... corporate milestones achieved since the beginning,of the quarter. ...
... Laboratories, Inc.,(NYSE: FRX ) today announced ... trial, published in the November 2007 issue ... that nebivolol,significantly reduced sitting diastolic and systolic ... with stage I-II hypertension.,The study also found ...
Cached Medicine Technology:Pharmacopeia Announces Third Quarter 2007 Financial Results 2Pharmacopeia Announces Third Quarter 2007 Financial Results 3Pharmacopeia Announces Third Quarter 2007 Financial Results 4Pharmacopeia Announces Third Quarter 2007 Financial Results 5Pharmacopeia Announces Third Quarter 2007 Financial Results 6Pharmacopeia Announces Third Quarter 2007 Financial Results 7Pharmacopeia Announces Third Quarter 2007 Financial Results 8Pharmacopeia Announces Third Quarter 2007 Financial Results 9Pharmacopeia Announces Third Quarter 2007 Financial Results 10Pharmacopeia Announces Third Quarter 2007 Financial Results 11UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension 2UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension 3
CHEMICON's Advanced Tissue Arrayer with patent-pending technology allows you to create customized arrays of multiple tissu specimens on a single slide, saving time and money....
CO2 gas object holder and knife freezer for the 8000 Series Sliding Microtome...
Tilt Adapter for the 8000 Sliding Microtome to allow for orientation of the specimen....
... 5040 microtome is of rotary retracting, self-lubricating design ... cutting arm. Its robust construction makes it accurate ... hinges means that all lateral motion is controlled ... be experienced in other, lesser designs which can ...
Medicine Products: